Space pure-plays sold off led by Rocket Lab −7.3% on its Iridium-deal dilution, while the only bid was diversified rad-hard silicon — STMicroelectronics +4.4%.

The space basket's only real strength came from the diversified edge of the map. STMicroelectronics (STM) rose 4.4% to $71.39, the top gainer, but the move was a broad semiconductor rebound rather than anything space-specific — STM is a watch-tier name on the rad-hard-silicon chokepoint, and it bounced with the same chip tape that lifted the compute and robotics complexes. Texas Instruments (TXN) +3.6% and Microchip (MCHP) +3.5% rode the same node. The signal: on a risk-off day for space, the bid went to companies whose space exposure is a rounding error.

The pure-plays were where the damage sat, led by Rocket Lab (RKLB), down 7.3% to $93.09. The market is still digesting Rocket Lab's roughly $8.0 billion cash-and-stock agreement to acquire Iridium (announced June 29; Iridium holders receive $27 in cash plus Rocket Lab shares), and Monday extended the de-rating on financing, dilution and integration risk after a strong run. Rocket Lab is the map's widest space name — launch, propulsion, optical terminals and space-solar power — so its unwind pulled the whole launch-and-infrastructure side down with it.

The selling was broad across the pure-play chokepoints. AST SpaceMobile (ASTS) fell 5.3% on the ground-segment/direct-to-device node, Karman (KRMN) 5.3% on propulsion, Satellogic (SATL) 4.6% and Spire (SPIR) 4.3% on earth observation, and Intuitive Machines (LUNR) 3.5% on in-space infrastructure. The one pure-play exception was MDA Space (MDA) +3.3% on that same in-space-infrastructure node. This was a session where capital rotated out of pre-revenue space narratives and toward the semiconductor names that merely touch the sector.

Earnings define the back half of July. Frequency Electronics reports fiscal Q4 on July 9, then Texas Instruments (July 21) and STMicroelectronics and L3Harris (both July 23) on the rad-hard-silicon and prime nodes, with Iridium's own Q2 on July 24 — a direct read on the ground-segment economics Rocket Lab is buying. Rocket Lab's Q2 (August 6), its first full quarter owning Mynaric and CONDOR, is the harder catalyst for the launch-and-optical chokepoints just repriced.